Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer

Hiroaki Ogata; Yuzo Yamamoto; Taishi Harada; Yoichi Nakanishi; Isamu Okamoto; Eiji Iwama; Eiji Iwama; Koji Kato; Yoshinao Oda

doi:10.1016/j.jtho.2016.12.023

Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer

Hiroaki Ogata, Yuzo Yamamoto, Taishi Harada, Yoichi Nakanishi, Isamu Okamoto, Eiji Iwama, Eiji Iwama, Koji Kato, Yoshinao Oda

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	e46-e47
Journal	Journal of Thoracic Oncology
Volume	12
Issue number	5
DOIs	https://doi.org/10.1016/j.jtho.2016.12.023
Publication status	Published - May 2017

All Science Journal Classification (ASJC) codes

Oncology
Pulmonary and Respiratory Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jtho.2016.12.023

Cite this

Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer. / Ogata, Hiroaki; Yamamoto, Yuzo; Harada, Taishi; Nakanishi, Yoichi; Okamoto, Isamu; Iwama, Eiji; Iwama, Eiji ; Kato, Koji ; Oda, Yoshinao.

In: Journal of Thoracic Oncology, Vol. 12, No. 5, 05.2017, p. e46-e47.

Research output: Contribution to journal › Letter › peer-review

@article{a9b22e0b1bd44afcb823a81a5434d936,

title = "Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer",

author = "Hiroaki Ogata and Yuzo Yamamoto and Taishi Harada and Yoichi Nakanishi and Isamu Okamoto and Eiji Iwama and Eiji Iwama and Koji Kato and Yoshinao Oda",

year = "2017",

month = may,

doi = "10.1016/j.jtho.2016.12.023",

language = "English",

volume = "12",

pages = "e46--e47",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "International Association for the Study of Lung Cancer",

number = "5",

}

TY - JOUR

T1 - Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer

AU - Ogata, Hiroaki

AU - Yamamoto, Yuzo

AU - Harada, Taishi

AU - Nakanishi, Yoichi

AU - Okamoto, Isamu

AU - Iwama, Eiji

AU - Kato, Koji

AU - Oda, Yoshinao

PY - 2017/5

Y1 - 2017/5

UR - http://www.scopus.com/inward/record.url?scp=85017658108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017658108&partnerID=8YFLogxK

U2 - 10.1016/j.jtho.2016.12.023

DO - 10.1016/j.jtho.2016.12.023

M3 - Letter

C2 - 28434513

AN - SCOPUS:85017658108

VL - 12

SP - e46-e47

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 5

ER -

Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this